Comparison of VentiBroncTM Anchor With Conventional Double-lumen Endobronchial Tube in Patients With High Risk of Malposition

Last updated: December 10, 2024
Sponsor: Yonsei University
Overall Status: Completed

Phase

N/A

Condition

Endotracheal Intubation

Treatment

conventional double-lumen intubation

Intubation with VentiBronc Anchor endobronchial double-lumen tube

Clinical Study ID

NCT06061055
1-2023-0043
  • Ages 20-85
  • All Genders

Study Summary

The investigators intend to compare the group using triple-cuffed endobronchial tube (VentiBroncTM Anchor) with the group using the conventional double-lumen endotracheal tube (Shiley®) in patients at high risk of malposition of the double-lumen endotracheal tube. The aim of this study is to determine if the use of VentiBroncTM Anchor increases the success rate of optimal double-lumen intubation to left main bronchus.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Patients requiring left double-lumen endotracheal tube intubation for thoracic surgery.

ASA physical status classification 2-4. Female patients aged 20-85 with a height of 160cm or less and a body mass index (BMI) of 25.0 kg/m2 or higher.

Patients requiring VentiBroncTM Anchor 33Fr or Shiley® 32Fr intubation due to a left mainstem bronchus diameter of 11mm or less on chest CT.

Exclusion

Exclusion Criteria:

Intraluminal lesions in the left or right mainstem bronchi. History of airway surgery. Emergency surgery.

Study Design

Total Participants: 154
Treatment Group(s): 2
Primary Treatment: conventional double-lumen intubation
Phase:
Study Start date:
October 26, 2023
Estimated Completion Date:
November 26, 2024

Connect with a study center

  • Severance hospital

    Seoul,
    Korea, Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.